Salt Lake City-based Xenter Inc. has named Dr. Mark Turco president of Xenter Medical Technologies, a Xenter business unit developing a platform of smart medical devices, initially focusing on vascular imaging and physiology technologies for interventional medical procedures. Xenter Medical Technologies was formerly known as Xenter Hospital Technologies.

Turco joins Xenter from Sirtex Medical where he served as executive vice president of research and development and global chief medical officer, leading the development and delivery of interventional oncology technologies. Prior to Sirtex, he was chief innovation and corporate outreach officer for the University of Pennsylvania’s Penn Center for Innovation, where he fostered multiple industry and academic partnerships across healthcare, engineering and business and established a new medical device center.

Turco began his 20-year clinical practice at Washington Adventist Hospital in Washington, D.C., where he served as the director of the Center for Cardiac and Vascular Research before joining Covidien as chief medical officer. Following Medtronic’s acquisition of Covidien in 2015, Turco was appointed vice president and chief medical officer of the Aortic, Peripheral & Vascular divisions at Medtronic prior to joining Penn.

“I am very excited to join Xenter in this pivotal leadership role,” said Turco. “I look forward to aiding in the development of medical technologies using Xenter’s three pillars: medical devices, health data and therapeutic drugs. I am joining a globally recognized and experienced team who has been tasked with transforming the collection of procedural and patient data using a new global platform that leverages smart wireless medical technologies. My combined experiences to date have provided me with the unique skills to lead this multi-disciplinary team of technologists, scientists and engineers.”

“Xenter is continuing our commitment to bringing the most experienced and visionary leaders to the world’s first purpose-built medical device-data-drug company and tasking them with introducing change, developing new wireless platforms for smart medical devices, and harnessing the power of physical intelligence to improve patient care,” said Richard J. Linder, founder, chairman and CEO of Xenter Inc. “Dr. Turco brings a wealth of skill and insight to Xenter and possesses the clinical knowledge and industry experience to drive the change we desire to achieve in medical devices and data.”

Pin It